Literature DB >> 3014152

Raised serum levels of IgM-rheumatoid factor and anti-F(ab')2 autoantibodies in patients with active inflammatory bowel disease.

F Pallone, P M Matricardi, O Squarcia, S Fais, S Le Moli, M Boirivant, P Paoluzi, R D'Amelio.   

Abstract

The serum levels of IgM-Rheumatoid Factor and of anti-F(ab')2 autoantibodies were investigated in patients with inflammatory Bowel Disease (IBD) by sensitive radioimmunoassays. Serum levels of the 2 autoantibodies were significantly increased in active IBD. In patients with Crohn's Disease raised titers of the 2 antibodies appeared to be also related to colonic involvement. There was, in Crohn's Disease, a significant association between concordantly positive results with the 2 assays and the occurrence of systemic complications. Immunocomplexes detected by the C1q-SP method were higher in sera of Crohn's Disease patients with raised IgM-RF than in the others. Data from the present investigation indicate that in active IBD and particularly in Crohn's Disease autoantibodies directed against different parts of the immunoglobulin molecule may be produced. These findings add support to the concept that an in vivo polyclonal B-cell activation may occur in these patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014152

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  6 in total

1.  The specificity of antiglobulin autoantibodies in patients with primary Sjögren's syndrome.

Authors:  T Wada; I Ezaki; M Shingu; S Nonaka; E Ohtsuka; M Yasuda; M Nobunaga
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

2.  Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.

Authors:  M R Capobianchi; S Fais; F Mercuri; M Boirivant; F Dianzani; F Pallone
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

4.  Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease.

Authors:  B R Yacyshyn; L M Pilarski
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

5.  Absence of circulating interferon in patients with inflammatory bowel disease. Suggestion against an autoimmune etiology.

Authors:  M R Capobianchi; S Fais; M C Di Paolo; D Agostini; P Paoluzi; F Pallone; F Dianzani
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

6.  Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.

Authors:  R P MacDermott; S Schreiber; G S Nash; W J Koopman
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.